FMP
NASDAQ
5.61 USD
-0.015 (-0.267%)
Mr. Amir London
Healthcare
Drug Manufacturers - Specialty & Generic
https://www.kamada.com
NASDAQ
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune therm...
0001567529
IL0010941198
M6240T109
2 Holzman Street
972 8 940 6472
IL
378
May 31, 2013
0001567529
NASDAQ
Drug Manufacturers -...
Healthcare
M6240T109
IL0010941198
IL
5.61
0.25
23.93k
322.43M
-
4.08-6.53
7.02
-
-
-
-
37.4
-
https://www.kamada.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.